Nasopharyngeal Squamous Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Nasopharyngeal Squamous Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation [NA]
A clinical trial update describes remote audiometry being studied to monitor treatment-related hearing loss in patients with head and neck s…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: Pembrolizumab Combined With Cetuximab for Treatment of Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma [Phase 2]
Phase 2 trial evaluating pembrolizumab in combination with cetuximab for recurrent/metastatic head and neck squamous cell carcinoma; the stu…
-
CLINICAL_TRIALS research · 2025-08-22Clinical Trial Update: Iparomlimab and Tuvonralimab Injection for Untreated Locally Advanced Nasopharyngeal Carcinoma [Phase 2]
Phase 2 trial update describing a study of Iparomlimab and Tuvonralimab for untreated locally advanced nasopharyngeal squamous cell carcinom…
-
CLINICAL_TRIALS trial_result · 2025-03-17Clinical Trial Update: Tolinapant and Radiation for Cisplatin-Ineligible, Previously Untreated, Locally Advanced Head and Neck Cancer [EARLY_Phase 1]
Early-phase trial evaluating Tolinapant in combination with radiation for cisplatin-ineligible, previously untreated locally advanced head a…
-
CLINICAL_TRIALS trial_result · 2024-10-29Clinical Trial Update: Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck Cancer [Phase 1]
This Phase 1 trial update reports the completion of a study evaluating image-guided proton therapy for locally advanced unresectable head an…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-07-31Clinical Trial Update: Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer [Phase 1]
Phase 1 trial of nab-paclitaxel (albumin-bound paclitaxel) with carboplatin followed by chemoradiation in patients with recurrent head and n…
-
CLINICAL_TRIALS trial_result · 2024-07-23Clinical Trial Update: Birinapant and Intensity Modulated Re-Irradiation Therapy in Treating Patients With Locally Recurrent Head and Neck Squamous Cell Carcinoma [Phase 1]
A Phase 1 trial evaluating birinapant in combination with intensity-modulated re-irradiation therapy for locally recurrent head and neck squ…
-
CLINICAL_TRIALS trial_result · 2023-07-19Clinical Trial Update: Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma [Phase 2]
Phase 2 trial evaluating ficlatuzumab with or without cetuximab in cetuximab-resistant recurrent or metastatic head and neck squamous cell c…
-
CLINICAL_TRIALS trial_result · 2021-08-20Clinical Trial Update: Concurrent Chemoradiotherapy With Toripalimab for Local-regional Recurrent Nasopharyngeal Carcinoma: a Prospective, Single-arm, Phase II Trial [Phase 2]
A Phase II prospective single-arm study evaluating concurrent chemoradiotherapy with toripalimab for locally recurrent nasopharyngeal carcin…
-
CLINICAL_TRIALS trial_result · 2021-01-29Clinical Trial Update: Optimized Treatment Strategies for Early and Medium Stage Nasopharyngeal Carcinoma [Phase 2, Phase 3]
Phase 2/3 trial update exploring optimized induction chemotherapy and concurrent chemoradiotherapy with reduced treatment intensity for naso…
-
CLINICAL_TRIALS trial_result · 2018-11-16Clinical Trial Update: Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer [NA]
A terminated clinical trial evaluating stereotactic body radiation therapy for high-risk locally advanced head and neck cancers; results wer…
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: Akt Inhibitor MK2206 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer [Phase 2]
This Phase 2 study evaluated the Akt inhibitor MK-2206 in patients with recurrent or metastatic nasopharyngeal squamous cell carcinoma. The …
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: Sunitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer [Phase 2]
Phase 2 clinical trial evaluating sunitinib for patients with recurrent or metastatic head and neck squamous cell carcinoma, with results po…
-
CLINICAL_TRIALS trial_result · 2014-01-07Clinical Trial Update: Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer [Phase 2]
Phase 2 trial evaluating lapatinib in recurrent and/or metastatic head and neck squamous cell carcinoma (including occult primary cases) has…
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Erlotinib Plus Docetaxel in Treating Patients With Locally Advanced, Metastatic, or Recurrent Head and Neck Cancer [Phase 1, Phase 2]
Phase 1/Phase 2 clinical trial evaluating the combination of erlotinib and docetaxel in patients with locally advanced, metastatic, or recur…
-
CLINICAL_TRIALS trial_result · 2013-10-30Clinical Trial Update: GP VS TP in the Treatment of Advanced Nasopharyngeal Carcinoma in Northwest China [Phase 2]
Phase 2 clinical trial evaluating GP versus TP regimens for advanced nasopharyngeal squamous cell carcinoma conducted in Northwest China; th…